ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
ACCURAY INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$0.14−0.01 (-8.16%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.5470 (−91.54%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ACCURAY INC saw revenue fall 12.3% to $401.95M over the twelve months to Jun 30, 2026. Operating income fell 437.3% to -$26.44M, moving the operating margin from 1.7% to -6.6%. Free cash flow was -$12.84M.
Revenue
$401.95M
-12.3% vs. a year earlier
Operating income
-$26.44M
-437.3% vs. a year earlier
Free cash flow
-$12.84M
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $401.95M
- Net income
- -$49.19M
- Free cash flow
- -$12.84M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$401.95M-12.3% YoY
Gross profit
$111.45M-24.2% YoY
Operating income
-$26.44M-437.3% YoY
Net income
-$49.19M
EPS, diluted
–
Free cash flow
-$12.84M
Reported period